We are live on ! Find out more
HIND

Vyome Holdings

10 hedge funds and large institutions have $49.1K invested in Vyome Holdings in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0% more funds holding

Funds holding: 1010 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

55% less capital invested

Capital invested by funds: $108K → $49.1K (-$59.2K)

Holders
10
Holders Change
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

HIND Hedge Fund Activity: Q1 2024 in Review

10 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Vyome Holdings (HIND) for Q1 2024, worth a combined $49.1K — down 55% from $108K a quarter earlier.

Fund positioning in HIND was balanced in Q1 2024: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $6.75K. The largest seller was Citadel Advisors, exiting entirely with an estimated $18.2K sold.

  • 10 institutional investors held Vyome Holdings (HIND) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $49.1K of Vyome Holdings stock for Q1 2024, down 55% quarter-over-quarter.
  • 3 funds opened new Vyome Holdings positions in Q1 2024 and 3 closed out, a net change of 0 holders.
  • The largest Vyome Holdings buyer in Q1 2024 was Tower Research Capital (TRC), an estimated $6.75K added.
  • The largest Vyome Holdings seller in Q1 2024 was Citadel Advisors, an estimated $18.2K sold.

Based on aggregated 13F filings for Q1 2024.